Skip to main content
Caplight Logo









BluumBio

BluumBio

Private
Berkeley, CaliforniaEnergy & Sustainabilityhttps://www.bluumbio.com/

Last Round

Seed

May 22, 2025

Est. Valuation

$1.79M

Total Funding Raised

$600,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

BluumBio is a biotechnology company that develops bio-based remediation solutions to remove toxic industrial pollutants from the environment.

Sector

Energy & Sustainability

Verticals

Biotechnology, Waste Management, Water Treatment

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Non-AI

Keywords

bioremediationmicrobial remediationenvironmental biotechbio-remediationwater treatmentsoil remediationPFAS remediationmicrobe-based cleanuphazardous waste treatmentindustrial cleanupgreen remediationbioreactorwaste managementnature-based solutionspollution control

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BluumBio Comparables

Compare BluumBio with similar companies based on industry and business-model similarity.

BluumBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fixed Earth Innovations
83%
Allied Microbiota
78%
Allonnia
78%

BluumBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 22, 2025
AcceleratorOct 15, 2024
GrantJun 6, 2022
SeedJan 5, 2022
AcceleratorSep 1, 2021
Accelerator
Aug 1, 2021

Key People

Founding team and executive leadership

Katherine French

Founder CEO

Founding Team

Jordan Baker

Chief Technology Officer

Executive Team

BluumBio Investors

Notable investors and investment history

BluumBio investors
InvestorRounds
Pareto VenturesSeed
EQT FoundationSeed
Founders FactoryAccelerator
Oxonian VenturesSeed
Hawktail ManagementSeed
Asymmetry VenturesSeed
Y CombinatorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors increased 42% MoM.

  • Sep 1, 2025

    Operations expanded into Australia and New Zealand with new offices.

BluumBio Filings

Explore SEC and related filing metadata, where available.

BluumBio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BluumBio's valuation, stock price, and market status.

Is BluumBio a public or private company?

BluumBio is a private company.

What is the current stock price of BluumBio?

BluumBio is a private company, so its shares have no public market price. Caplight tracks BluumBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is BluumBio worth (valuation)?

BluumBio's valuation is estimated at $1.8M based on funding round data.

Can I buy BluumBio stock?

BluumBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was BluumBio's last funding round?

BluumBio's most recent funding round was Seed on May 22, 2025.

Who are the main investors in BluumBio?

Key investors in BluumBio include Pareto Ventures, Y Combinator, Activate, Day One Ventures, Liquid 2 Ventures.

Will BluumBio IPO soon?

No public IPO plans have been announced for BluumBio.

How can I track BluumBio secondary market activity?

Caplight tracks bids, offers, and trades in BluumBio's shares on secondary markets.

Firmographic Details

HeadquartersBerkeley, California
Employee Range6
Year Founded2021
Last FundingMay 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?